Arrowhead Pharmaceuticals Inc (ARWR)

Total asset turnover

		Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	US$ in thousands	3,471	222,409	243,231	138,287	87,992
Total assets	US$ in thousands	1,139,800	765,552	691,939	710,148	522,504
Total asset turnover		0.00	0.29	0.35	0.19	0.17

September 30, 2024 calculation

Total asset turnover = Revenue ÷ Total assets
= $3,471K ÷ $1,139,800K
= 0.00

Arrowhead Pharmaceuticals Inc's total asset turnover has fluctuated over the past five years. The highest total asset turnover was observed in September 2022 at 0.35, indicating that the company generated $0.35 in revenue for each dollar of total assets during that period. This suggests that the company efficiently utilized its assets to generate sales.

In contrast, the total asset turnover dropped to 0.17 in September 2020, reflecting a lower level of revenue generation relative to total assets invested. However, the ratio improved in subsequent years, reaching 0.29 in September 2023 and 0.00 in September 2024.

The significant drop to 0.00 in September 2024 could indicate a potential decline in revenue relative to total assets or a change in the composition of assets. Further analysis is needed to understand the reasons behind this decrease and its implications for the company's operational efficiency and financial performance.